Journal Information

Statistics

Follow this link to access the full text of the article

PP 37
INTEGRATED EFFICACY RESULTS FROM THE PHASE 2 AND PHASE 3 STUDIES WITH CAPLACIZUMAB IN PATIENTS WITH ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA
Flora Peyvandi1, Spero Cataland2, Marie Scully3, Paul Coppo4, Paul Knoebl5, Johanna A. Kremer Hovinga6, Ara Metjian7, Javier de la Rubia8, Katerina Pavenski9, Jessica Minkue Mi Edou10, Filip Callewaert11, Hilde De Winter12
1 Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, and Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy
2 Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA
3 Department of Haematology, University College London Hospitals NHS Trust, London, UK
4 Department of Hematology, Reference Center for Thrombotic Microangiopathies (CNR-MAT), Saint-Antoine University Hospital, AP-HP, Paris, France
5 Department of Medicine 1, Division of Hematology and Hemostasis, Medical University of Vienna, Austria
6 Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
7 Division of Hematology, Department of Medicine, University of Colorado–Anschutz Medical Center, Denver, CO, USA
8 Hematology Department, Internal Medicine, School of Medicine and Dentistry, Catholic University of Valencia and Hospital Doctor Peset, Valencia, Spain
9 Departments of Medicine and Laboratory Medicine, St. Michael's Hospital and University of Toronto, Toronto, ON, Canada
10 Clinical Development, Ablynx, a Sanofi company, Ghent, Belgium
11 Medical Affairs, Sanofi, Diegem, Belgium
12 Formerly Clinical Development, Ablynx, a Sanofi company, Ghent, Belgium
Ver más
Read
1428
Times
was read the article
675
Total PDF
753
Total HTML
Share statistics
Article information
ISSN: 25311379
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 May 7 7 14
2024 April 26 26 52
2024 March 28 24 52
2024 February 27 29 56
2024 January 26 23 49
2023 December 24 21 45
2023 November 41 31 72
2023 October 31 57 88
2023 September 50 31 81
2023 August 23 11 34
2023 July 34 12 46
2023 June 40 23 63
2023 May 29 16 45
2023 April 18 12 30
2023 March 24 25 49
2023 February 18 13 31
2023 January 20 12 32
2022 December 28 20 48
2022 November 22 19 41
2022 October 25 14 39
2022 September 26 23 49
2022 August 21 13 34
2022 July 23 37 60
2022 June 23 31 54
2022 May 13 8 21
2022 April 23 18 41
2022 March 19 37 56
2022 February 17 18 35
2022 January 13 18 31
2021 December 22 27 49
2021 November 12 19 31
Show all

Follow this link to access the full text of the article

Idiomas
Hematology, Transfusion and Cell Therapy